» Articles » PMID: 24771842

Introducing Genetic Testing for Cardiovascular Disease in Primary Care: a Qualitative Study

Overview
Journal Br J Gen Pract
Specialty Public Health
Date 2014 Apr 29
PMID 24771842
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While primary care systematically offers conventional cardiovascular risk assessment, genetic tests for coronary heart disease (CHD) are increasingly commercially available to patients. It is unclear how individuals may respond to these new sources of risk information.

Aim: To explore how patients who have had a recent conventional cardiovascular risk assessment, perceive additional information from genetic testing for CHD.

Design And Setting: Qualitative interview study in 12 practices in Nottinghamshire from both urban and rural settings.

Method: Interviews were conducted with 29 adults, who consented to genetic testing after having had a conventional cardiovascular risk assessment.

Results: Individuals' principal motivation for genetic testing was their family history of CHD and a desire to convey the results to their children. After testing, however, there was limited recall of genetic test results and scepticism about the value of informing their children. Participants dealt with conflicting findings from the genetic test, family history, and conventional assessment by either focusing on genetic risk or environmental lifestyle factors. In some participants, genetic test results appeared to reinforce healthy behaviour but others were falsely reassured, despite having an 'above-average' conventional cardiovascular risk score.

Conclusion: Although genetic testing was acceptable, participants were unclear how to interpret genetic risk results. To facilitate healthy behaviour, health professionals should explore patients' understanding of genetic test results in light of their family history and conventional risk assessment.

Citing Articles

Demographic Determinants Influencing the Adoption of Genetic Testing for Cardiovascular Diseases in Japan - Insights From a Large-Scale Online Survey.

Isa K, Suzuki T, Nomura S, Miyoshi T, Fujita K, Kubo T Circ Rep. 2024; 6(5):178-182.

PMID: 38736847 PMC: 11081704. DOI: 10.1253/circrep.CR-24-0028.


Precision Medicine-Are We There Yet? A Narrative Review of Precision Medicine's Applicability in Primary Care.

Evans W, Meslin E, Kai J, Qureshi N J Pers Med. 2024; 14(4).

PMID: 38673045 PMC: 11051552. DOI: 10.3390/jpm14040418.


Acceptability of predictive testing for ischemic heart disease in those with a family history and the impact of results on behavioural intention and behaviour change: a systematic review.

Wells I, Simons G, Davenport C, Mallen C, Raza K, Falahee M BMC Public Health. 2022; 22(1):1751.

PMID: 36109776 PMC: 9479351. DOI: 10.1186/s12889-022-14116-6.


Polygenic risk scores: improving the prediction of future disease or added complexity?.

Ayoub A, McHugh J, Hayward J, Rafi I, Qureshi N Br J Gen Pract. 2022; 72(721):396-398.

PMID: 35902257 PMC: 9343049. DOI: 10.3399/bjgp22X720437.


Cardiovascular risk communication strategies in primary prevention. A systematic review with narrative synthesis.

Schulberg S, Ferry A, Jin K, Marshall L, Neubeck L, Strachan F J Adv Nurs. 2022; 78(10):3116-3140.

PMID: 35719002 PMC: 9546276. DOI: 10.1111/jan.15327.


References
1.
Cameron L, Sherman K, Marteau T, Brown P . Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol. 2009; 28(3):307-16. DOI: 10.1037/a0013947. View

2.
Sanderson S, Michie S . Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet. 2007; 71(6):501-10. DOI: 10.1111/j.1399-0004.2007.00810.x. View

3.
Skirton H, Goldsmith L, Jackson L, OConnor A . Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet. 2012; 82(3):210-8. DOI: 10.1111/j.1399-0004.2012.01863.x. View

4.
Gollust S, Hull S, Wilfond B . Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA. 2002; 288(14):1762-7. DOI: 10.1001/jama.288.14.1762. View

5.
Johnson K, Trimbath J, Petersen G, Griffin C, Giardiello F . Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test. 2003; 6(4):303-6. DOI: 10.1089/10906570260471831. View